Filter:
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
Clark reviews findings from a 3-year longitudinal study comparing VCTE to liver biopsy for staging F2/F3 fibrosis in patients with […]
Read More… from Dr. Virginia Clark findings from comparison of VCTE FibroScan to Liver Biopsy
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
Strnad emphasizes the promise offered by RNA therapeutics in liver disease and what potential fazirsiran may hold for AATD liver […]
October 22, 2025- The Alpha-1 Foundation (A1F) is proud to share the news that Sanofi’s efdoralprin alfa has met all […]
Read More… from Positive results from Sanofi’s Phase 2 Investigational Drug
The 28th Gordon L. Snider (GLS) Critical Issues Workshop entitled, “AAT Polymers: Disease Pathogenesis, Detection, and Therapeutic Targeting” took place […]
Read More… from A1F 28th Gordon L. Snider Critical Issues Workshop
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
On Monday, May 19th, 2025, the Alpha-1 Foundation (A1F) hosted its annual A1F Grants Award Reception at the San Francisco […]
Read More… from A1F recognizes 2025 Grant Award Recipients during ATS
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation’s (A1F) 7th Global Research Conference & 10th Patient Congress kicks off today in Lisbon, Portugal. With a […]
Korro Bio has completed the dosing of the first two single ascending dose cohorts in healthy adult volunteers. They continue […]
Read More… from Korro Bio provides update on progress made: KRRO-110
Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency “This exciting study provides evidence of […]
Read More… from Nature Genetics: Alpha-1 Research Publication March 2025
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
Watch her video interview here. New data from the open-label extension of the phase 2b SEQUOIA study of fazirsiran support […]
Read More… from Virginia Clark, MD: Understanding Fazirsiran’s Potential in AATD Liver Disease
Experimental Models of Alpha-1 Antitrypsin Deficiency Lung and Liver Disease The Alpha-1 Foundation joined with researchers, clinicians and industry partners […]
Read More… from 27th Gordon L. Snider (GLS) Critical Issues Workshop
The Alpha-1 Foundation is proud to provide a monthly list of articles from researchers that have been funded by the […]
